These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 20530671)

  • 1. HPV16 E2 is an immediate early marker of viral infection, preceding E7 expression in precursor structures of cervical carcinoma.
    Xue Y; Bellanger S; Zhang W; Lim D; Low J; Lunny D; Thierry F
    Cancer Res; 2010 Jul; 70(13):5316-25. PubMed ID: 20530671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus 16 E6/E7 transcript and E2 gene status in patients with cervical neoplasia.
    Sathish N; Abraham P; Peedicayil A; Sridharan G; John S; Chandy G
    Mol Diagn; 2004; 8(1):57-64. PubMed ID: 15230643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profiling of serum antibodies against human papillomavirus antigens in Korean women with cervical intraepithelial neoplasia and cervical cancer.
    Jin Y; Choi JW; Kim HJ; Eddouzi J; Kim SC; Ju W; Kim YH; Kim HJ
    Cancer Med; 2018 Nov; 7(11):5655-5664. PubMed ID: 30353680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and epigenetic changes of HPV16 in cervical cancer differentially regulate E6/E7 expression and associate with disease progression.
    Mazumder Indra D; Singh RK; Mitra S; Dutta S; Chakraborty C; Basu PS; Mondal RK; Roychoudhury S; Panda CK
    Gynecol Oncol; 2011 Dec; 123(3):597-604. PubMed ID: 21911249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility study of a human papillomavirus E6 and E7 oncoprotein test for the diagnosis of cervical precancer and cancer.
    Zhang JJ; Cao XC; Zheng XY; Wang HY; Li YW
    J Int Med Res; 2018 Mar; 46(3):1033-1042. PubMed ID: 29322839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV16 positive women for high-grade cervical lesions.
    Cricca M; Morselli-Labate AM; Venturoli S; Ambretti S; Gentilomi GA; Gallinella G; Costa S; Musiani M; Zerbini M
    Gynecol Oncol; 2007 Sep; 106(3):549-57. PubMed ID: 17568661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of E6 and E7 levels in high-risk HPV16 type cervical lesions with CCL20 and Langerhans cells.
    Jiang B; Xue M
    Genet Mol Res; 2015 Sep; 14(3):10473-81. PubMed ID: 26400278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The physical state of HPV16 infection and its clinical significance in cancer precursor lesion and cervical carcinoma.
    Li W; Wang W; Si M; Han L; Gao Q; Luo A; Li Y; Lu Y; Wang S; Ma D
    J Cancer Res Clin Oncol; 2008 Dec; 134(12):1355-61. PubMed ID: 18478264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The value of P16/ki67 double labeling, HPV E6/E7 mRNA detection and their combined application in cytological shunt diagnosis of low-grade squamous intraepithelial lesions].
    Guan Y; Peng J; Yuan C; Mi X; Chen Z; Chen J; Chen A; Liu J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Jan; 36(1):63-68. PubMed ID: 32314725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of HPV E6/E7 mRNA combined with P16/ki67 immunocytochemistry in the diagnosis of atypical squamous cells of undetermined significance(ASCUS)].
    Zhan X; Wang S; Wu X; Qiu X; Li F; Zeng Y; Chen Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Oct; 34(10):937-941. PubMed ID: 30554588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus 16 load and E2/E6 ratio in HPV16-positive women: biomarkers for cervical intraepithelial neoplasia >or=2 in a liquid-based cytology setting?
    Boulet GA; Benoy IH; Depuydt CE; Horvath CA; Aerts M; Hens N; Vereecken AJ; Bogers JJ
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):2992-9. PubMed ID: 19861526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HR-HPV E6/E7 mRNA In Situ Hybridization: Validation Against PCR, DNA In Situ Hybridization, and p16 Immunohistochemistry in 102 Samples of Cervical, Vulvar, Anal, and Head and Neck Neoplasia.
    Mills AM; Dirks DC; Poulter MD; Mills SE; Stoler MH
    Am J Surg Pathol; 2017 May; 41(5):607-615. PubMed ID: 28403015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies against human papillomavirus (HPV) type 16 and 18 E2, E6 and E7 proteins in sera: correlation with presence of papillomavirus DNA.
    Rosales R; López-Contreras M; Cortes RR
    J Med Virol; 2001 Dec; 65(4):736-44. PubMed ID: 11745939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E2/E6 ratio and L1 immunoreactivity as biomarkers to determine HPV16-positive high-grade squamous intraepithelial lesions (CIN2 and 3) and cervical squamous cell carcinoma.
    Choi YJ; Lee A; Kim TJ; Jin HT; Seo YB; Park JS; Lee SJ
    J Gynecol Oncol; 2018 May; 29(3):e38. PubMed ID: 29400024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of antibody to E2 protein of human papillomavirus and p16
    Chuerduangphui J; Pientong C; Swangphon P; Luanratanakorn S; Sangkomkamhang U; Tungsiriwattana T; Kleebkaow P; Burassakarn A; Ekalaksananan T
    Med Oncol; 2018 May; 35(6):93. PubMed ID: 29744680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel MLL5 isoform that is essential to activate E6 and E7 transcription in HPV16/18-associated cervical cancers.
    Yew CW; Lee P; Chan WK; Lim VK; Tay SK; Tan TM; Deng LW
    Cancer Res; 2011 Nov; 71(21):6696-707. PubMed ID: 21908553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variability and functional implication of HPV16 from cervical intraepithelial neoplasia in Shanghai women.
    Zhao J; Zhu J; Guo J; Zhu T; Zhong J; Liu M; Ruan Y; Liao S; Li F
    J Med Virol; 2020 Mar; 92(3):372-381. PubMed ID: 31670402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPV-16 E2 physical status and molecular evolution in vivo in cervical carcinomas.
    Kahla S; Kochbati L; Chanoufi MB; Maalej M; Oueslati R
    Int J Biol Markers; 2014 Mar; 29(1):e78-85. PubMed ID: 24170557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-risk human papillomavirus E6/E7 mRNA and L1 DNA as markers of residual/recurrent cervical intraepithelial neoplasia.
    Persson M; Brismar Wendel S; Ljungblad L; Johansson B; Weiderpass E; Andersson S
    Oncol Rep; 2012 Jul; 28(1):346-52. PubMed ID: 22484610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TLR9 expression in uterine cervical lesions of Uyghur women correlate with cervical cancer progression and selective silencing of human papillomavirus 16 E6 and E7 oncoproteins in vitro.
    Hao Y; Yuan JL; Abudula A; Hasimu A; Kadeer N; Guo X
    Asian Pac J Cancer Prev; 2014; 15(14):5867-72. PubMed ID: 25081715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.